{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:06:35Z","timestamp":1778493995845,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ejso.2018.06.023","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T14:26:20Z","timestamp":1530973580000},"page":"1371-1377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Single centre guidelines for radiological follow-up based on 775 patients treated by cytoreductive surgery and HIPEC for appendiceal pseudomyxoma peritonei"],"prefix":"10.1016","volume":"44","author":[{"given":"Kim","family":"Govaerts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Chandrakumaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman J.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas D.","family":"Cecil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Dayal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faheez","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Thrower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan J.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejso.2018.06.023_bib1","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejso.2007.04.002","article-title":"Appendiceal neoplasms and pseudomyxoma peritonei: a population based study","volume":"34","author":"Smeenk","year":"2008","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2018.06.023_bib2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1055-3207(03)00026-7","article-title":"The etiology, clinical presentation, and management of pseudomyxoma peritonei","volume":"12","author":"Moran","year":"2003","journal-title":"Surg Oncol Clin"},{"issue":"4","key":"10.1016\/j.ejso.2018.06.023_bib3","first-page":"411","article-title":"Pseudomyxoma peritonei usually originates from the appendix: a review of the evidence","volume":"25","author":"Mukherjee","year":"2004","journal-title":"Eur J Gynaecol Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2018.06.023_bib4","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/jclinpath-2012-200843","article-title":"Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases","volume":"65","author":"Carr","year":"2012","journal-title":"J\u00a0Clin Pathol"},{"issue":"4","key":"10.1016\/j.ejso.2018.06.023_bib5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/jso.21054","article-title":"Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei)","volume":"98","author":"Moran","year":"2008","journal-title":"J\u00a0Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2018.06.023_bib6","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ejso.2016.03.017","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours","volume":"42","author":"Ansari","year":"2016","journal-title":"Eur J Surg Oncol"},{"issue":"20","key":"10.1016\/j.ejso.2018.06.023_bib7","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2018.06.023_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","article-title":"A\u00a0consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the peritoneal surface oncology group international (PSOGI) modified delphi process","volume":"40","author":"Carr","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.ejso.2018.06.023_bib9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ejso.2014.08.476","article-title":"Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours","volume":"41","author":"Lord","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2018.06.023_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ejso.2018.06.023_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/ejso.2000.1038","article-title":"Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome","volume":"27","author":"Sugarbaker","year":"2001","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2018.06.023_bib12","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1463-1318.2005.00773.x","article-title":"Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence","volume":"7","author":"Alexander-Sefre","year":"2005","journal-title":"Colorectal Dis"},{"issue":"8","key":"10.1016\/j.ejso.2018.06.023_bib13","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1245\/s10434-007-9393-9","article-title":"Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"14","author":"Baratti","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2018.06.023_bib14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/jso.20107","article-title":"Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix","volume":"87","author":"Carmignani","year":"2004","journal-title":"J\u00a0Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2018.06.023_bib15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejso.2013.12.021","article-title":"Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal Pseudomyxoma Peritonei: analysis of 519 patients","volume":"40","author":"Taflampas","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2018.06.023_bib16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ejso.2016.10.009","article-title":"The modified Glasgow prognosis score predicts for overall and disease-free survival following cytoreductive surgery and HIPEC in patients with pseudomyxoma peritonei of appendiceal origin","volume":"43","author":"Tan","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"13","key":"10.1016\/j.ejso.2018.06.023_bib17","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1245\/s10434-016-5389-7","article-title":"Advanced pseudomyxoma peritonei requiring gastrectomy to achieve complete cytoreduction results in good long-term oncologic outcomes","volume":"23","author":"Di Fabio","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2018.06.023_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/PPO.0b013e3181a9c781","article-title":"Epithelial appendiceal neoplasms","volume":"15","author":"Sugarbaker","year":"2009","journal-title":"Cancer J"},{"issue":"1","key":"10.1016\/j.ejso.2018.06.023_bib19","first-page":"3","article-title":"Peritoneal dissemination from high-grade appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"7","author":"Cummins","year":"2016","journal-title":"J\u00a0Gastrointest Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2018.06.023_bib20","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1245\/s10434-012-2788-2","article-title":"Surveillance MR imaging is superior to serum tumor markers for detecting early tumor recurrence in patients with appendiceal cancer treated with surgical cytoreduction and HIPEC","volume":"20","author":"Low","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2018.06.023_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1515\/pp-2016-0008","article-title":"Pathophysiology and classification of pseudomyxoma peritonei","volume":"1","author":"Bignell","year":"2016","journal-title":"Pleura Peritoneum"},{"issue":"3","key":"10.1016\/j.ejso.2018.06.023_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1001\/jama.2013.285718","article-title":"Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial","volume":"311","author":"Primrose","year":"2014","journal-title":"JAMA"},{"issue":"34","key":"10.1016\/j.ejso.2018.06.023_bib23","doi-asserted-by":"crossref","first-page":"8664","DOI":"10.1200\/JCO.2005.01.6071","article-title":"Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials","volume":"23","author":"Sargent","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"33","key":"10.1016\/j.ejso.2018.06.023_bib24","doi-asserted-by":"crossref","first-page":"8512","DOI":"10.1200\/JCO.2005.04.0063","article-title":"Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline","volume":"23","author":"Desch","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"Suppl.\u00a05","key":"10.1016\/j.ejso.2018.06.023_bib25","article-title":"Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up","volume":"21","author":"Labianca","year":"2010","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2018.06.023_bib26","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1245\/s10434-016-5388-8","article-title":"Posttreatment surveillance in patients with prolonged disease-free survival after resection of colorectal liver metastasis","volume":"23","author":"Galjart","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2018.06.023_bib27","article-title":"Operating to remove recurrent colorectal cancer: have we got it right?","volume":"348","author":"Treasure","year":"2014","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.ejso.2018.06.023_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004385","article-title":"The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer","volume":"4","author":"Treasure","year":"2014","journal-title":"BMJ Open"},{"issue":"22","key":"10.1016\/j.ejso.2018.06.023_bib29","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMra072149","article-title":"Computed tomography\u2013an increasing source of radiation exposure","volume":"357","author":"Brenner","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ejso.2018.06.023_bib30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/153537020523000201","article-title":"Health risks of low-dose ionizing radiation in humans","volume":"230","author":"Bianca","year":"2005","journal-title":"Exp Biol Med (Maywood)"},{"issue":"4","key":"10.1016\/j.ejso.2018.06.023_bib31","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1667\/RR0553.1","article-title":"The 15-country collaborative study of cancer risk among radiation workers in the nuclear industry: estimates of radiation-related cancer risks","volume":"167","author":"Cardis","year":"2007","journal-title":"Radiat Res"},{"issue":"5","key":"10.1016\/j.ejso.2018.06.023_bib32","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1245\/s10434-014-4041-7","article-title":"Comparison of MRI and CT for predicting the Peritoneal Cancer Index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures","volume":"22","author":"Low","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2018.06.023_bib33","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ejso.2016.01.005","article-title":"Preoperative\u00a0CT\u00a0and MRI prediction of non-resectability in patients treated for pseudomyxoma peritonei from mucinous appendiceal neoplasms","volume":"42","author":"Menassel","year":"2016","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2018.06.023_bib34","first-page":"283","article-title":"Physical and mental health among cancer survivors: considerations for long-term care and quality of life","volume":"75","author":"Naughton","year":"2014","journal-title":"N\u00a0C Med J"},{"issue":"6","key":"10.1016\/j.ejso.2018.06.023_bib35","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/bjs.10716","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin","volume":"105","author":"Delhorme","year":"2018","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.ejso.2018.06.023_bib36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejso.2016.08.021","article-title":"Long-term survival after aggressive treatment of relapsed serosal or distant pseudomyxoma peritonei","volume":"43","author":"Delhorme","year":"2017","journal-title":"Eur J Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798318311673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798318311673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:26:10Z","timestamp":1760059570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798318311673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0748798318311673"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2018.06.023","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single centre guidelines for radiological follow-up based on 775 patients treated by cytoreductive surgery and HIPEC for appendiceal pseudomyxoma peritonei","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2018.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}